Kai Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KAI PHARMS INC, and what generic alternatives to KAI PHARMS INC drugs are available?
KAI PHARMS INC has one approved drug.
There are seven US patents protecting KAI PHARMS INC drugs.
There are eighty-four patent family members on KAI PHARMS INC drugs in forty-three countries and seventeen supplementary protection certificates in fifteen countries.
Drugs and US Patents for Kai Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-001 | Feb 7, 2017 | RX | Yes | Yes | 11,162,500 | See Plans and Pricing | Y | See Plans and Pricing | |||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-002 | Feb 7, 2017 | RX | Yes | Yes | 8,377,880 | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-003 | Feb 7, 2017 | RX | Yes | Yes | 9,278,995 | See Plans and Pricing | Y | See Plans and Pricing | |||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-001 | Feb 7, 2017 | RX | Yes | Yes | 8,999,932 | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-001 | Feb 7, 2017 | RX | Yes | Yes | 9,820,938 | See Plans and Pricing | Y | See Plans and Pricing | |||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-002 | Feb 7, 2017 | RX | Yes | Yes | 9,278,995 | See Plans and Pricing | Y | See Plans and Pricing | |||
Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-003 | Feb 7, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kai Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Cyprus | 1118388 | See Plans and Pricing |
South Korea | 20160043954 | See Plans and Pricing |
Denmark | 2459208 | See Plans and Pricing |
Japan | 2016523916 | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2011014707 | See Plans and Pricing |
South Africa | 201600238 | See Plans and Pricing |
San Marino | T201700014 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kai Pharms Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2459208 | 122017000021 | Germany | See Plans and Pricing | PRODUCT NAME: ETELCALCETID ODER EIN SALZ DAVON; REGISTRATION NO/DATE: EU/1/16/1142 20161111 |
2459208 | SPC/GB17/018 | United Kingdom | See Plans and Pricing | PRODUCT NAME: ETELCALCETIDE, OR A SALT THEROF, INCLUDING ETELCALCETIDE HYDROCHLORIDE; REGISTERED: UK EU/1/16/1142/001-012 20161115; UK PLGB 13832/0039 20161115; UK PLGB 13832/0040 20161115; UK PLGB 13832/0041 20161115 |
2459208 | PA2017007 | Lithuania | See Plans and Pricing | PRODUCT NAME: ETELKALCETIDAS ARBA JO DRUSKA, ISKAITANT ETELKALCETIDO HIDROCHLORIDA; REGISTRATION NO/DATE: EU/1/16/1142 20161111 |
2459208 | C20170006 00208 | Estonia | See Plans and Pricing | PRODUCT NAME: ETELKALTSETIID;REG NO/DATE: EU/1/16/1142 15.11.2016 |
2459208 | CR 2017 00006 | Denmark | See Plans and Pricing | PRODUCT NAME: ETELCALCETID ELLER ET SALT DERAF, INKLUSIV ETELCALCETIDHYDROCHLORID; REG. NO/DATE: EU/1/16/1142/001-012 20161115 |
2459208 | 654 | Finland | See Plans and Pricing | |
2459208 | LUC00008 | Luxembourg | See Plans and Pricing | PRODUCT NAME: ETELCALCETIDE, OU UN SEL EQUIVALENT, Y COMPRIS LE CHLORHYDRATE D'ETELCALCETIDE (PARSABIV); AUTHORISATION NUMBER AND DATE: EU/1/16/1142 20161115 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.